Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
20.3%
% of XBI's 119 holdings also in PBE
85.7%
% of PBE's 28 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 2.6% | 5.0% | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.5% | 4.4% | 2.5% |
|
NATERA INC | 2.5% | 4.7% | 2.5% |
|
BIOGEN IDEC INC | 2.5% | 5.0% | 2.5% |
|
AMGEN INC | 2.4% | 5.0% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to PBE
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
ABBVIE INC | 2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.3% |
|
MODERNA, INC. | 2.2% |
|
VAXCYTE, INC. | 2.1% |
|
BRIDGEBIO PHARMA, INC. | 1.6% |
|
SAREPTA THERAPEUTICS INC | 1.6% |
|
CYTOKINETICS INC | 1.5% |
XBI Underweight Relative to PBE
|
ILLUMINA INC | -4.3% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.4% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
CATALYST PHARMACEUTICAL PART | -2.7% |
|
GILEAD SCIENCES INC | -2.7% |
|
ROYALTY PHARMA PLC CLASS A | -2.6% |
|
BIO-TECHNE CORPORATION | -2.6% |
|
AMGEN INC | -2.6% |
|
BIOGEN IDEC INC | -2.5% |
|
NEUROCRINE BIOSCIENCES INC | -2.4% |